Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Oxford Nanopore Technologies PLC ( (GB:ONT) ) just unveiled an update.
Oxford Nanopore Technologies reported a strong trading performance for 2025, expecting full-year revenue of approximately £223–224 million, up about 22% on a reported basis and 24% at constant currency, slightly ahead of its guidance. Growth was broad-based across regions, with all major geographies delivering more than 20% constant currency revenue increases, and across end markets, led by around 60% growth in Clinical revenue, 30% in BioPharma and 27% in Applied Industrial, while Research revenue rose about 15% despite funding pressures. Product demand was driven particularly by the PromethION range, which grew more than 40% year-on-year, underscoring continued adoption of its high-throughput platforms. The group also highlighted progress on its path to profitability and ended 2025 with roughly £302 million in cash and liquid investments, ahead of consensus expectations, providing a solid capital base to support its strategy. Oxford Nanopore plans to publish its preliminary results for the year ended 31 December 2025 on 2 March 2026, accompanied by a management presentation and Q&A.
The most recent analyst rating on (GB:ONT) stock is a Hold with a £140.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Spark’s Take on GB:ONT Stock
According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.
The overall stock score of 51 reflects a combination of financial challenges and technical weaknesses, offset by positive earnings guidance and corporate governance initiatives. The company’s revenue growth and strategic focus on improving profitability are promising, but current financial and market conditions pose significant risks.
To see Spark’s full report on GB:ONT stock, click here.
More about Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies is a life sciences and biotechnology company that has developed nanopore-based sensing technology for real-time, high-performance DNA and RNA analysis. Its sequencing platforms are used in more than 125 countries across research, clinical, biopharma, applied industrial and pathogen surveillance applications, with potential impact in healthcare, food and agriculture.
Average Trading Volume: 1,713,192
Technical Sentiment Signal: Sell
Current Market Cap: £1.36B
For detailed information about ONT stock, go to TipRanks’ Stock Analysis page.